These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 25248030)

  • 1. Longitudinal costs of caring for people with Alzheimer's disease.
    Gillespie P; O'Shea E; Cullinan J; Buchanan J; Bobula J; Lacey L; Gallagher D; Mhaolain AN; Lawlor B;
    Int Psychogeriatr; 2015 May; 27(5):847-56. PubMed ID: 25248030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of dependence and function on costs of care for Alzheimer's disease and mild cognitive impairment in Ireland.
    Gillespie P; O'Shea E; Cullinan J; Lacey L; Gallagher D; Ni Mhaolain A;
    Int J Geriatr Psychiatry; 2013 Mar; 28(3):256-64. PubMed ID: 23386588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of costs of care for patients with Alzheimer's disease.
    Jönsson L; Eriksdotter Jönhagen M; Kilander L; Soininen H; Hallikainen M; Waldemar G; Nygaard H; Andreasen N; Winblad B; Wimo A
    Int J Geriatr Psychiatry; 2006 May; 21(5):449-59. PubMed ID: 16676288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between global severity of patients with Alzheimer's disease and costs of care in Spain; results from the co-dependence study in Spain.
    Darbà J; Kaskens L; Lacey L
    Eur J Health Econ; 2015 Nov; 16(8):895-905. PubMed ID: 25348897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of FDA approved medications for Alzheimer's disease in mild dementia is associated with reduced informal costs of care.
    Behrens S; Rattinger GB; Schwartz S; Matyi J; Sanders C; DeBerard MS; Lyketsos CG; Tschanz JT
    Int Psychogeriatr; 2018 Oct; 30(10):1499-1507. PubMed ID: 29559029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient dependence and longitudinal changes in costs of care in Alzheimer's disease.
    Zhu CW; Leibman C; McLaughlin T; Zbrozek AS; Scarmeas N; Albert M; Brandt J; Blacker D; Sano M; Stern Y
    Dement Geriatr Cogn Disord; 2008; 26(5):416-23. PubMed ID: 18946219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost and care of patients with Alzheimer's disease: clinical predictors in German health care settings.
    Reese JP; Hessmann P; Seeberg G; Henkel D; Hirzmann P; Rieke J; Baum E; Dannhoff F; Müller MJ; Jessen F; Geldsetzer MB; Dodel R
    J Alzheimers Dis; 2011; 27(4):723-36. PubMed ID: 21876256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation between severity of Alzheimer's disease and costs of caring.
    Hux MJ; O'Brien BJ; Iskedjian M; Goeree R; Gagnon M; Gauthier S
    CMAJ; 1998 Sep; 159(5):457-65. PubMed ID: 9757169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics and longitudinal changes of informal cost of Alzheimer's disease in the community.
    Zhu CW; Scarmeas N; Torgan R; Albert M; Brandt J; Blacker D; Sano M; Stern Y
    J Am Geriatr Soc; 2006 Oct; 54(10):1596-602. PubMed ID: 17038080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use and costs of formal care in newly diagnosed dementia: a three-year prospective follow-up study.
    Vossius C; Rongve A; Testad I; Wimo A; Aarsland D
    Am J Geriatr Psychiatry; 2014 Apr; 22(4):381-8. PubMed ID: 23567428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cost of Alzheimer's disease in managed care: a cross-sectional study.
    Leon J; Neumann PJ
    Am J Manag Care; 1999 Jul; 5(7):867-77. PubMed ID: 10557408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of full costs of care for patients with Alzheimer's disease in France: the predominant role of informal care.
    Gervès C; Chauvin P; Bellanger MM
    Health Policy; 2014 May; 116(1):114-22. PubMed ID: 24461717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The GERAS Study: a prospective observational study of costs and resource use in community dwellers with Alzheimer's disease in three European countries--study design and baseline findings.
    Wimo A; Reed CC; Dodel R; Belger M; Jones RW; Happich M; Argimon JM; Bruno G; Novick D; Vellas B; Haro JM
    J Alzheimers Dis; 2013; 36(2):385-99. PubMed ID: 23629588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of patient function and dependence on costs of care in Alzheimer's disease.
    Zhu CW; Leibman C; McLaughlin T; Scarmeas N; Albert M; Brandt J; Blacker D; Sano M; Stern Y
    J Am Geriatr Soc; 2008 Aug; 56(8):1497-503. PubMed ID: 18662215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of time to institutionalisation and related healthcare and societal costs in a community-based cohort of patients with Alzheimer's disease dementia.
    Belger M; Haro JM; Reed C; Happich M; Argimon JM; Bruno G; Dodel R; Jones RW; Vellas B; Wimo A
    Eur J Health Econ; 2019 Apr; 20(3):343-355. PubMed ID: 30178148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective one-year cost-of-illness study in a cohort of patients with dementia of Alzheimer's disease type in Spain: the ECO study.
    Coduras A; Rabasa I; Frank A; Bermejo-Pareja F; López-Pousa S; López-Arrieta JM; Del Llano J; León T; Rejas J
    J Alzheimers Dis; 2010; 19(2):601-15. PubMed ID: 20110605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Costs of care in a mild-to-moderate Alzheimer clinical trial sample: key resources and their determinants.
    Gustavsson A; Cattelin F; Jönsson L
    Alzheimers Dement; 2011 Jul; 7(4):466-73. PubMed ID: 21784355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of societal costs in Alzheimer's disease: GERAS study baseline results.
    Dodel R; Belger M; Reed C; Wimo A; Jones RW; Happich M; Argimon JM; Bruno G; Vellas B; Haro JM
    Alzheimers Dement; 2015 Aug; 11(8):933-45. PubMed ID: 25846298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resource Use and Cost of Alzheimer's Disease in France: 18-Month Results from the GERAS Observational Study.
    Rapp T; Andrieu S; Chartier F; Deberdt W; Reed C; Belger M; Vellas B
    Value Health; 2018 Mar; 21(3):295-303. PubMed ID: 29566836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frailty: a costly phenomenon in caring for elders with cognitive impairment.
    Butler A; Gallagher D; Gillespie P; Crosby L; Ryan D; Lacey L; Coen R; O'Shea E; Lawlor B
    Int J Geriatr Psychiatry; 2016 Feb; 31(2):161-8. PubMed ID: 26136186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.